Baird Bullish on Pharmacyclics (PCYC) Following ASCO Abstracts
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Buy Incyte Genomics, Inc. (INCY) and Pharmacyclics (PCYC) Into ASCO Meeting
May 15, 2014 8:46 AM EDTNomura analyst M. Ian Somaiya is telling clients to buy Incyte Genomics, Inc. (NASDAQ: INCY) and Pharmacyclics, Inc. (NASDAQ: PCYC) following ASCO abstracts and into the meeting.
Somaiya comments, "We are buyers of INCY and... More
Drugs Stocks on Watch Ahead of ASCO Abstracts Release
May 14, 2014 3:13 PM EDTAbstracts for ASCO's 50th annual meeting taking place May 30 through June 3 are expected to be release tonight at around 5 pm (Link Here).
Stocks on watch include Bristol-Myers Squibb Co. (NYSE: BMY), Merck & Co., Inc. (NYSE:... More
